HALO
Halozyme Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.94 / 10
Underperform
The fundamental analysis reveals a score of 2.94/10, indicating underperform quality. Key weaknesses include low Net profit / Total profit ratio (80.76%) and negative Asset-MV (-0.50), while Cash-MV (-0.15) and Profit-MV (0.96) show marginal improvement. Overall, the fundamental profile warrants a defensive stance due to limited profitability and asset efficiency.
Analysis Checks(7/10)
Revenue-MV
Value-0.96
Score1/3
Weight10.77%
1M Return5.20%
Value-0.96
Score1/3
Weight10.77%
1M Return5.20%
Gross profit margin (%)
Value84.12
Score2/3
Weight2.67%
1M Return1.47%
Value84.12
Score2/3
Weight2.67%
1M Return1.47%
PB-ROE
Value3.04
Score2/3
Weight22.64%
1M Return10.68%
Value3.04
Score2/3
Weight22.64%
1M Return10.68%
Fixed assets turnover ratio
Value23.20
Score2/3
Weight0.21%
1M Return0.12%
Value23.20
Score2/3
Weight0.21%
1M Return0.12%
Cash-MV
Value-0.15
Score2/3
Weight16.15%
1M Return7.73%
Value-0.15
Score2/3
Weight16.15%
1M Return7.73%
Inventory turnover ratio
Value0.92
Score2/3
Weight-4.09%
1M Return-2.63%
Value0.92
Score2/3
Weight-4.09%
1M Return-2.63%
Profit-MV
Value0.96
Score2/3
Weight16.13%
1M Return7.79%
Value0.96
Score2/3
Weight16.13%
1M Return7.79%
Current assets turnover ratio
Value0.78
Score1/3
Weight-0.81%
1M Return-0.48%
Value0.78
Score1/3
Weight-0.81%
1M Return-0.48%
Asset-MV
Value-0.50
Score2/3
Weight36.80%
1M Return15.13%
Value-0.50
Score2/3
Weight36.80%
1M Return15.13%
Net profit / Total profit (%)
Value80.76
Score0/3
Weight-0.48%
1M Return-0.30%
Value80.76
Score0/3
Weight-0.48%
1M Return-0.30%
Revenue-MV
Value-0.96
Score1/3
Weight10.77%
1M Return5.20%
Value-0.96
Score1/3
Weight10.77%
1M Return5.20%
Inventory turnover ratio
Value0.92
Score2/3
Weight-4.09%
1M Return-2.63%
Value0.92
Score2/3
Weight-4.09%
1M Return-2.63%
Gross profit margin (%)
Value84.12
Score2/3
Weight2.67%
1M Return1.47%
Value84.12
Score2/3
Weight2.67%
1M Return1.47%
Profit-MV
Value0.96
Score2/3
Weight16.13%
1M Return7.79%
Value0.96
Score2/3
Weight16.13%
1M Return7.79%
PB-ROE
Value3.04
Score2/3
Weight22.64%
1M Return10.68%
Value3.04
Score2/3
Weight22.64%
1M Return10.68%
Current assets turnover ratio
Value0.78
Score1/3
Weight-0.81%
1M Return-0.48%
Value0.78
Score1/3
Weight-0.81%
1M Return-0.48%
Fixed assets turnover ratio
Value23.20
Score2/3
Weight0.21%
1M Return0.12%
Value23.20
Score2/3
Weight0.21%
1M Return0.12%
Asset-MV
Value-0.50
Score2/3
Weight36.80%
1M Return15.13%
Value-0.50
Score2/3
Weight36.80%
1M Return15.13%
Cash-MV
Value-0.15
Score2/3
Weight16.15%
1M Return7.73%
Value-0.15
Score2/3
Weight16.15%
1M Return7.73%
Net profit / Total profit (%)
Value80.76
Score0/3
Weight-0.48%
1M Return-0.30%
Value80.76
Score0/3
Weight-0.48%
1M Return-0.30%
Is HALO undervalued or overvalued?
- HALO scores 2.94/10 on fundamentals and holds a Premium valuation at present. Backed by its 105.67% ROE, 47.91% net margin, 15.96 P/E ratio, 18.85 P/B ratio, and 58.96% earnings growth, these metrics solidify its Underperform investment rating.
